Esophageal adenocarcinoma

There are 47 papers on esophageal adenocarcinoma in aging research: 1 trial and 21 observational studies in people, 1 in cells, 14 reviews. The newest story, Nov 17, 2026: “Barrett’s esophagus may begin decades before diagnosis”.

Disease

47 papers study it6 more mention it13 findings

6 new papers in 30 daysSee all 53 papers on esophageal adenocarcinoma

“but not with AC risk (0.92 [0.76, 1.12]), after adjustment for consumption frequency.”
Hot Drinks and Oesophageal Cancer: Prospective Analyses in Around 1 Million UK AdultsInternational journal of cancer2026doi:10.1002/ijc.70654
  • Human trial1
  • Humans21
  • Cells1
  • In silico8

Interventions

3

Nonsteroidal anti-inflammatory drugs

downin reviews1

1 study
  1. Nonsteroidal anti-inflammatory drugs prevent esophageal adenocarcinoma.

    “Nonsteroidal anti-inflammatory drugs appear to prevent EAC”

    Review

    Opportunities for Preventing Esophageal Adenocarcinoma

    Cancer prevention research (Philadelphia, Pa.)

More on Nonsteroidal anti-inflammatory drugs

Smoking cessation

downin reviews1

1 study
  1. Smoking cessation prevents esophageal adenocarcinoma.

    “Preventive effects were found on the basis of medium-level observational evidence following treatment of gastroesophageal reflux disease (using both medication and surgery) and tobacco smoking cessation”

    Review

    Opportunities for Preventing Esophageal Adenocarcinoma

    Cancer prevention research (Philadelphia, Pa.)

More on Smoking cessation

Gastroesophageal reflux disease treatment

downin reviews1

1 study
  1. Gastroesophageal reflux disease treatment prevents esophageal adenocarcinoma.

    “Preventive effects were found on the basis of medium-level observational evidence following treatment of gastroesophageal reflux disease (using both medication and surgery) and tobacco smoking cessation”

    Review

    Opportunities for Preventing Esophageal Adenocarcinoma

    Cancer prevention research (Philadelphia, Pa.)

More on Gastroesophageal reflux disease treatment

Upstream

2

Metabolic syndrome

no changein humans1

1 study
  1. Metabolic syndrome was not clearly linked with esophageal adenocarcinoma in humans (Compared with matched Barrett esophagus controls).

    “MetS was not found to be associated with EA risk when compared with Barrett esophagus controls.”

    HumansCompared with matched Barrett esophagus controlsn = 575

    Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data

    Cancer

More on Metabolic syndrome

Telomere length

no changein humans1

1 study
  1. Telomere length was not clearly linked with esophageal adenocarcinoma in humans (compared to population-based controls).

    “The findings do not suggest a relationship between LTL and BE or EAC.”

    Humanscompared to population-based controls

    Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma

    Cancer medicine

More on Telomere length

Associations

8

Barrett's esophagus dwell time

upin humans1

1 study
  1. Esophageal adenocarcinoma is associated with Barrett's esophagus dwell time in humans (Median dwell time difference 12.5 years; p=0.0002).

    “Estimated dwell times were longer in patients with concurrent dysplasia (median difference 14.3 years; p=0.0042) or EAC (12.5 years; p=0.0002) than matched non-dysplastic BE controls.”

    HumansConcurrent esophageal adenocarcinoma compared with age- and sex-matched non-dysplastic Barrett's esophagus controlsesophagus

    Barrett’s esophagus may begin decades before diagnosis

    medRxivPreprint

More on Barrett's esophagus dwell time

Hot drinks

no changein humans1RR 0.92

1 study
  1. Hot drinks are associated with esophageal adenocarcinoma in humans (RR 0.92, 95% CI 0.76-1.12).

    “but not with AC risk (0.92 [0.76, 1.12]), after adjustment for consumption frequency.”

    Humansn = 977,282

    Hot Drinks and Oesophageal Cancer: Prospective Analyses in Around 1 Million UK Adults

    International journal of cancer

More on Hot drinks

Smoking

upin humans1RR 2.25

1 study
  1. Smoking is linked with a higher risk of esophageal adenocarcinoma in humans (current vs never smokers) (RR 2.25 (95% CI: 1.80-2.82)).

    “2.25 (95% CI: 1.80-2.82; n = 14) for adenocarcinoma (OAC)”

    Humanscurrent vs never smokers

    Evaluating the effect of cigarettes smoking on oesophageal cancer risk: a systematic review and meta-analysis with dose-response relationships

    European journal of public health

More on Smoking

CNA-based biological age

upin humans1

1 study
  1. Esophageal adenocarcinoma is associated with CNA-based biological age in humans.

    “Applied to a matched esophageal cohort, the clock detected accelerated aging from normal squamous epithelium through Barrett’s esophagus to esophageal adenocarcinoma”

    Humansmatched esophageal cohort; normal squamous epithelium through Barrett’s esophagus to esophageal adenocarcinomaesophageal epithelium

    Somatic copy-number alteration signatures reveal sex-divergent aging trajectories accelerated in cancer

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on CNA-based biological age

Biological-age acceleration

upin humans1HR 1.79

1 study
  1. Biological-age acceleration is linked with a higher risk of esophageal adenocarcinoma in humans (adjusted HR 1.79 (95% CI: 1.52-2.10)).

    “Compared with biologically younger participants, those older had higher risk of EAC, with adjusted HR of 1.79 (95%CI: 1.52-2.10).”

    Humans13.70 yearsn = 362,310

    Impact of accelerated biological aging and genetic variation on esophageal adenocarcinoma: Joint and interaction effect in a prospective cohort

    International journal of cancer

More on Biological-age acceleration

Hormone replacement therapy

downin humans1HR 0.78

1 study
  1. Hormone replacement therapy is linked with a lower risk of esophageal adenocarcinoma in humans (overall) (HR 0.78, 95% CI 0.63-0.97).

    “Ever-users of menopausal hormonal therapy had an overall decreased risk of oesophageal adenocarcinoma (HR 0.78, 95% CI 0.63-0.97)”

    Humansoverallsystemicesophagusfemales

    Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study

    British journal of cancer

More on Hormone replacement therapy

Dietary magnesium

upin humans1

1 study
  1. Dietary magnesium is linked with a higher risk of esophageal adenocarcinoma in humans (only among participants with low calcium:magnesium intake ratios).

    “There was a positive association between increasing magnesium intake and OAC risk, but only among participants with low calcium:magnesium intake ratios (p-trend 0.04).”

    Humansonly among participants with low calcium:magnesium intake ratios

    Associations between calcium and magnesium intake and the risk of incident oesophageal cancer: an analysis of the NIH-AARP Diet and Health Study prospective cohort

    British journal of cancer

More on Dietary magnesium

Metabolic syndrome

upin humans1OR 1.16

1 study
  1. Metabolic syndrome is associated with esophageal adenocarcinoma in humans (Compared with matched population controls) (OR 1.16, 95% CI 1.06–1.26).

    “EA was found to be significantly associated with MetS (odds ratio, 1.16; 95% confidence interval, 1.06-1.26) compared with population controls.”

    HumansCompared with matched population controlsn = 3,167

    Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data

    Cancer

More on Metabolic syndrome

Trial sponsors

Funding

6 grants since 2017

National Cancer Institute$17M

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 5Mar 2026: 1Apr 2026: 0May 2026: 1Jun 2026: 1Jul 2026: 1Aug 2026: 5Sep 2026: 4Oct 2026: 5Nov 2026: 227 papers in 12 months
medRxiv

Barrett’s esophagus may begin decades before diagnosis

A DNA-based clock estimated median onset ages of 29.5 and 29.3 years in two groups of people with Barrett’s esophagus.A DNA-based clock estimated median onset ages of 29.5 and 29.3 years in two groups of people with Barrett’s esophagus.

Preprint: cross-sectional studyEsophageal adenocarcinoma
medRxiv

DNA changes in Barrett’s esophagus traced back decades

An observational preprint involving 80 people found that the timing and pace of DNA changes predicted cancer risk better than their extent alone.An observational preprint involving 80 people found that the timing and pace of DNA changes predicted cancer risk better than their extent alone.

Preprint: cohort · 71 peopleMechanisms
JAMA Surgery

Weight-loss surgery linked to lower obesity-related cancer risk

Compared with no surgery, weight-loss surgery was associated with a lower obesity-related cancer rate, with an adjusted rate ratio of 0.81.Compared with no surgery, weight-loss surgery was associated with a lower obesity-related cancer rate, with an adjusted rate ratio of 0.81.

Cohort · 784,105 peopleObesity-related cancer

See all 53 papers on esophageal adenocarcinoma